Table 1 Participant characteristics
Patient characteristics (n = 24) | |
 Gender, n(%) | Female 11 (46%) Male 13 (54%) |
 Age Range, n(%) | 41–50, 1 (4%) 51–60, 4 (17%) 61–70, 6 (25%) 71–80, 5 (21%) 81–90, 5 (21%) > = 91, 3 (12%) |
 Diagnoses, n(%) | Cancer 15 (63%) Amyotrophic lateral sclerosis 3 (12%) Cardiovascular/Respiratory 4 (17%) Other neurological 1 (4%) Other (hotel) 1 (4%) |
 Current location, n(%) | Hospital 18 (75%) Home 5 (21%) Other 1 (4%) |
 European Cooperative Oncology Group Functional Status, n(%) | 0, 1: 0 2: 3 (12%) 3: 8 (32%) 4: 8 (32%) Unreported/unsure: 5 (20%) |
 Preferred location of assisted dying, n(%) | Home 6 (24%) Hospice 1 (4%) Hospital 12 (50%) No preference 3 (12%) Other 2 (18%) |
 Preferred route of medications for assisted dying, n(%) | Oral medications 1 (4%) Intravenous 17 (71%) No preference 6 (25%) |
 Preferred timing of assisted dying, n(%) | Within one week 10 (42%) One week to one month 4 (17%) Greater than one month 5 (21%) No preference 5 (21%) |
Family member characteristics (n = 17) | |
 Gender, n(%) | Male 3 (18%) Female 13 (76%) Declined to answer 1 (6%) |
 Age Range, n(%) | 21–30, 1 (6%) 31–40, 0 41–50, 1 (6%) 51–60, 3 (18%) 61–70, 9 (53%) 71–80, 2 (12%) 81–90, 1 (6%) |
 Location, n(%) | Ontario, 15 (88%) British Columbia, 1 (6%) Nova Scotia, 1 (6%) |
 Relationship to patient, n(%) | Spouse/partner 6 (35%) Child 7 (41%) Sibling 2 (12%) Friend 2 (12%) |